Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Champions Oncology (CSBR) Shares Issued (2016 - 2026)

Champions Oncology has reported Shares Issued over the past 16 years, most recently at $3000.0 for Q1 2026.

  • Quarterly results put Shares Issued at $3000.0 for Q1 2026, down 92.11% from a year ago — trailing twelve months through Jan 2026 was $240000.0 (down 23.81% YoY), and the annual figure for FY2025 was $320000.0, up 26.48%.
  • Shares Issued for Q1 2026 was $3000.0 at Champions Oncology, down from $207000.0 in the prior quarter.
  • Over the last five years, Shares Issued for CSBR hit a ceiling of $276000.0 in Q4 2024 and a floor of -$1000.0 in Q2 2023.
  • Median Shares Issued over the past 5 years was $24000.0 (2025), compared with a mean of $75076.9.
  • Biggest five-year swings in Shares Issued: surged 3300.0% in 2022 and later crashed 106.25% in 2023.
  • Champions Oncology's Shares Issued stood at $86000.0 in 2022, then soared by 179.07% to $240000.0 in 2023, then rose by 15.0% to $276000.0 in 2024, then fell by 25.0% to $207000.0 in 2025, then plummeted by 98.55% to $3000.0 in 2026.
  • The last three reported values for Shares Issued were $3000.0 (Q1 2026), $207000.0 (Q4 2025), and $24000.0 (Q3 2025) per Business Quant data.